12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy
    Journal Article

    Takahashi, Y.; Eguchi, T.; Bains, S.; Adusumilli, P. S.
    Annals of Translational Medicine (2016)

    Fulltext@MSK | Save
  • Improved noninvasive prostate cancer assessment using multiparametric magnetic resonance imaging
    Conference Paper

    Li, X.; Singanamalli, A.; Shanbhag, D.; Hötker, A. M.; Aras, O.; Akin, O.; Bhagalia, R.
    IEEE (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
    Journal Article

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sabari, J.; Woo, K. M.; Plodkowski, A.; Wang, L.; Hellmann, M. D.; Joubert, P.; Sima, C. S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • A functional assay for homologous recombination (HR) DNA repair and whole exome sequencing reveal that HR-defective sporadic breast cancers are enriched for genetic alterations in DNA repair genes
    Meeting Abstract

    Powell, S. N.; Riaz, N.; Mutter, R. W.; Ng, C. K. Y.; Delsite, R.; Piscuoglio, S.; King, T. A.; Martelotto, L.; Sakr, R.; Brogi, E.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Single cell sequencing analysis of formalin-fixed paraffin-embedded ductal carcinomas in situ and invasive breast cancers reveals clonal selection in the progression from in situ to invasive disease
    Meeting Abstract

    Martelotto, L. G.; Baslan, T.; Kendall, J.; Rodgers, L.; Cox, H.; King, T. A.; Weigelt, B.; Hicks, J.; Reis-Filho, J. S.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Neratinib for ERBB2 mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial
    Meeting Abstract

    Hyman, D. M.; Piha-Paul, S. A.; Rodón, J.; Saura, C.; Puzanov, I.; Shapiro, G. I.; Loi, S.; Joensuu, H.; Hanrahan, A. J.; Modi, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase II, randomized, parallel-cohort study of neoadjuvant buparlisib (BKM120) in combination with trastuzumab and paclitaxel in women with HER2-positive, PIK3CA mutant and PIK3CA wild-type primary breast cancer - NeoPHOEBE
    Meeting Abstract

    Loibl, S.; de la Pena, L.; Nekljudova, V.; Zardavas, D.; Michiels, S.; Denkert, C.; Rezai, M.; Bermejo, B.; Lee, S. C.; Turri, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Immunotherapy of malignant pleural mesothelioma using cMET specific T-cells
    Meeting Abstract

    Thayaparan, T.; van der Stegen, S. J. C.; Puri, Acpp; Petrovic, R. M.; Spicer, J.; Maher, J.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Treg inhibition by anti-GITR therapy evokes therapeutic antitumor responses selectively in the context of a pro-inflammatory tumor microenvironment
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Liu, C.; Draleau, K.; Schaer, D.; Zhong, H.; Yang, X.; Merghoub, T.; Wolchok, J. D.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Cooperative defense against acute Clostridium difficile infection is mediated by two innate lymphoid cell subsets
    Meeting Abstract

    Abt, M. C.; Lewis, B. B.; Ling, L. L.; Carter, R. A.; Susac, B.; Pamer, E. G.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save